2-((2R,3R)-3-(tert-butyl)-4(2,6-dimethoxyphenyl)-2,3dihydrobenzo[d][1,3]oxaphosphol-2-yl)pyridine, 97%, 100mg

tert-Butyl (2S,5R)-2-ethyl-5-methylpiperazine-1-carboxylate, 95+%, 500mg

Recipiente de reacción con brida plana, cilíndrico, graduado, con camisa de templado y vacío y válvula de drenaje, DN 100, 3000 ml, 250 mm, 1 pieza

6-(2,5-Dihydroxyphenyl)dibenzo[c,e][1,2]oxaphosphinine 6-Oxide>95.0%(HPLC)(qNMR)25g

5-(Trifluoromethyl)isoxazole-3-carboxylic acid, 98+%, 1g

(2S,4R)-4-Fluoro-2-methylpyrrolidine hydrochloride, 100mg

Boc-L-(4-Fmoc)-Aminophenylalanine, 95.0%, 5g

8,9-Dihydro-5H-5,9-methanobenzo[7]annulen-7(6H)-one, 97%, 100mg

2-Methylamino-nicotinic acid, 95.0%, 250mg

Ampollas precortadas Vidrio transparente, 5 ml, 144 Pieza(s)

5-Chloro-2-(chloromethyl)thiazole, 98%, 50mg

Isobutil éster de ácido acético, mínimo 99 %, para síntesis, 100 ml, envase de vidrio

Bomba de vacío de membrana MD 1 serie MD 1, 1 pieza